Protalix BioTherapeutics, Inc. (PLX) - Insider Holders & Insider Ownership

List of insiders holdings for Protalix BioTherapeutics, Inc.:

Shares directly owned by the insider.
Shares indirectly owned by the insider.
Total shares owned by the insider (sum of shares directly and indirectly owned).
Total market value if available.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

#	Insider Holder Name	Report Date Time	Shares Owned Directly Indirectly	Total Shares Owned	Filing
1	Sheratzki Eyal Director 10% Owner	2007-01-05 20:27:25	0 14,466,319	14,466,319	Form 4
2	Bio-Cell Ltd 10% Owner	2014-09-18 17:59:19	0 10,066,319	10,066,319	Form 4
3	Hurvitz Eli Director	2009-11-13 16:30:40	4,898,683 4,898,683	9,797,366	Form 4
4	Toussia-Cohen Sharon Director 10% Owner	2007-01-05 20:28:07	0 6,556,381	6,556,381	Form 4
5	Techno-Rov Holdings (1993) Ltd 10% Owner	2007-01-05 20:28:26	0 6,186,046	6,186,046	Form 4
6	Marathon Investments Ltd. 10% Owner	2009-09-24 11:00:46	4,777,304 0	4,777,304	Form 13G
7	Akirov Alfred Director	2020-03-30 14:12:47	3,332,862 0	3,332,862	Form 13G
8	FROST PHILLIP MD Frost Gamma Investments Trust 10% Owner	2011-01-20 16:18:28	3,076,106 0	3,076,106	Form 13D
9	Dexcel Pharma Technologies Ltd. Oren Dan 10% Owner	2021-06-15 09:19:55	2,034,117 0	2,034,117	Form 13G
10	Camber Capital Management LLC 10% Owner	2017-02-14 12:01:14	1,562,933 0	1,562,933	Form 13G
11	Manor Moshe President & CEO	2018-09-14 16:30:40	1,300,000 0	1,300,000	Form 4
12	HSIAO JANE PH D Director	2007-02-02 18:18:06	1,134,060 0	1,134,060	Form 4
13	Shaaltiel Yoseph Executive VP, R&D	2018-09-14 16:30:18	700,000 0	700,000	Form 4
14	Maimon Yossi VP, Chief Financial Officer	2018-09-14 16:31:39	700,000 0	700,000	Form 4
15	Rubin Eyal Sr. VP and CFO	2024-11-05 17:00:15	0 660,909	660,909	Form 4/A
16	Mamlok Gilad Sr. VP and CFO	2026-04-27 17:00:21	601,621 0	601,621	Form 3/A
17	Bashan Dror PRESIDENT AND CEO	2026-09-04 06:00:19	480,000 0	480,000	Form 4
18	Aviezer David President & CEO	2012-07-18 16:31:13	0 418,000	418,000	Form 4
19	Katz Iftah VP of Operations	2007-06-13 15:50:55	204,351 0	204,351	Form 4
20	Almon Einat Brill SVP, Chief Development Officer	2020-06-08 17:07:44	196,995 0	196,995	Form 4
21	Naos Yaron Sr. VP & COO	2026-09-04 06:00:25	168,000 0	168,000	Form 4
22	Yanai Shlomo Director	2014-07-24 16:35:33	150,000 0	150,000	Form 4
23	Palash Tzvi Chief Operating Officer	2015-05-07 17:23:01	125,000 0	125,000	Form 4
24	Bronfeld Zeev Director	2022-09-09 17:01:49	100,000 0	100,000	Form 4
25	Hayon Yael VP, Research & Development	2023-08-17 16:30:28	35,115 35,115	70,230	Form 4
26	Kornberg Roger D. Director	2008-09-08 20:26:12	50,000 0	50,000	Form 4
27	Granot David Director	2020-01-22 17:03:26	40,000 0	40,000	Form 4
28	Bar-Shalev Amos Director	2026-09-04 06:00:19	25,500 0	25,500	Form 4
29	Boudes Pol F Director	2026-09-04 06:00:21	25,500 0	25,500	Form 4
30	Melincoff Gwen A Director	2026-09-04 06:00:23	25,500 0	25,500	Form 4
31	Forster Eliot Director	2026-09-04 06:00:14	25,500 0	25,500	Form 4
32	Ben Zvi Shmuel Director	2026-09-04 06:00:17	25,500 0	25,500	Form 4
33	Elze Christian Director	2026-09-04 06:00:23	25,500 0	25,500	Form 4
34	Schwartz Aharon Director	2026-09-09 17:00:46	25,500 0	25,500	Form 4
35	Lauterbach Sandra Leigh VP, Sales & Commercial Affairs	2012-07-18 16:40:33	0 20,000	20,000	Form 4
36	Lockshin Curtis Director	2007-03-29 17:00:07	0 0	0	Form 3
37	Gross Yodfat Harel Director	2007-07-12 17:12:04	0 0	0	Form 3
38	Buchris Pinhas Barel Director	2007-01-05 19:33:15	0 0	0	Form 3